21st.BIO A/S: Financial statements 2024
CVR: 41554908
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
21st.BIO A/S (CVR 41554908) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -17,202,758 and a net result of DKK -41,660,123 compared with DKK -42,260,118 the year before. Equity in the 2024 report amounted to DKK 330,332,139. The solvency ratio was 74.9%. The company had 19 employees in the financial year.
- Gross Profit
- DKK -17,202,758
- Profit/Loss
- DKK -41,660,123
- Equity
- DKK 330,332,139
- Total Assets
- DKK 440,894,061
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -17.2 mio. | -41.7 mio. | 330.3 mio. | 19 |
| 2023 | - | -9.8 mio. | -42.3 mio. | 294.8 mio. | 32 |
| 2022 | - | -21.9 mio. | -36.6 mio. | 262.6 mio. | 11 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 31, 2024, Novo Holdings A/S is registered as an owner of 21st.BIO A/S with an ownership share of 33%.
21st.BIO A/S has published its annual report for 2023. Gross profit came to DKK -9,825,858, and the net result was DKK -42,260,118.
About 21st.BIO A/S
21st.BIO A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Copenhagen Bio Partners A/S. The management consists of Henrik Marcus Geertz-Hansen, Jose Arnau Martinez and Mikael Bechsgaard. The board consists of Anders Bendsen Spohr (chair), Claus Crone Fuglsang, Thomas Dal Stenfeldt Batchelor and Thomas Grotkjær. The company is owned by Novo Holdings A/S, NOVOZYMES A/S and Momentum Techinvest ApS. The company has 44 employees (2026). In 2025, the company reported a gross profit of DKK -15,518,420 and a net result of DKK -127,801,300 compared with DKK -41,660,123 the year before. Equity in the 2025 report amounted to DKK 202,530,839.